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Severe protein 
restriction reduces 
blood pressure
Hypertension is a well-known 
concomitant of chronic kidney disease 
and can clearly be controlled by removal 
of fl uid during dialysis. Bellizzi et al. in 
this issue studied the eff ect of dietary 
management on blood pressure control 
in severe renal disease. Th ey placed 
patients on three diets of varying protein 
restriction. Some were placed on a 
low-protein diet, others were placed on 
severe protein restriction supplemented 
by the ketoanalogs of essential amino 
acids, and a third group were placed 
on an ad libitum diet. Aft er the patients 
were placed on these diets, their dietary 
protein intake 6 months later refl ected the 
initial prescription. Th e blood pressure 
decreased only in patients on the very-
low-protein diet despite reduction of 
antihypertensive drugs. Urinary urea 
excretion directly correlated with urinary 
sodium excretion, which diminished 
in the patients on the very-low-protein 
diet. Daily sodium excretion was also 
measured. Th e authors found that the 
blood pressure was independently related 
to urinary sodium excretion and the 
very-low-protein diet, but not to the level 
of protein intake. Th e results demonstrate 
the primacy of salt excretion, that is, salt 
intake in the hypertension of chronic 
kidney disease, but also that severe 
protein restriction (while maintaining 
essential amino acid intake) might also 
play a part. See page 245.
Obesity, 
hyperfiltration, and 
salt
Th ere is no doubt that obesity increases 
the risk of long-term renal damage. In 
addition, there have been syndromes of 
specifi c glomerulosclerosis that seems 
to be associated with massive obesity. 
What could be the mechanism for this? 
Krikken et al. in this issue propose that 
renal hemodynamics in obese people 
might be involved in this problem; 
they studied the interaction between a 
high-salt diet and renal blood fl ow and 
glomerular fi ltration rate. Th ey placed 
healthy subjects on low- or high-salt 
diets and found that the fi ltration rate 
and the eff ective renal plasma fl ow 
increased when subjects were changed 
from a low-salt to a high-salt diet, as 
has been found previously. Th ey found 
that there was a good correlation 
between the glomerular fi ltration rate 
or fi ltration fraction and the body 
mass index, but only during high-salt 
feeding. Interestingly, for subjects with 
a high body mass index, the eff ects of a 
high-salt diet on the fi ltration rate and 
fi ltration fraction were signifi cantly 
diff erent. Th e fi ltration fraction was 
signifi cantly higher in obese subjects, 
but only during a high-salt diet. Th ese 
results suggest that high-salt feeding in 
obese subjects causes hyperfi ltration and 
may contribute to the kidney damage 
seen in obesity. One should point 
out that the high-salt diet contained 
200 mmol of Na, close to the average diet 
of industrialized countries. 
See page 260.
Endostatin in 
peritoneal fibrosis
Peritoneal fi brosis is one of the major 
complications of chronic ambulatory 
peritoneal dialysis. Studies in 
experimental and human dialysis 
showed that new vessel formation seems 
to be involved in the fi brosis, and it 
seems that vascular endothelial growth 
factor (VEGF) is increased under some 
circumstances of peritoneal dialysis. 
In this issue, Tanabe et al. examine the 
effi  cacy of endostatin in preventing 
peritoneal fi brosis. Endostatin is a 
peptide fragment from collagen XI 
that is known to be antiangiogenic 
in a variety of systems. Th e authors 
induced peritoneal infl ammation by 
instilling chlorhexidine gluconate into 
the peritoneal cavities of mice and 
found that subcutaneous delivery of 
endostatin reduced the accumulation 
of collagen I and collagen III. As 
expected from its antiangiogenic action, 
it also reduced the number of blood 
vessels. Th ere was also a reduction in 
macrophages. Endostatin also reduced 
the expression of VEGF-A and TGF-
β1. Th ere was a reduction in cells 
expressing α-smooth muscle actin. All 
of these results suggest that endostatin 
might be a useful reagent to reduce 
infl ammation in the peritoneum. Th ere 
is much interest in the use of endostatin 
for malignant tumors, and the results 
of Tanabe et al. suggest that, at least in 
this system of peritoneal infl ammation, 
endostatin might be a useful adjunct 
in the fi brosis seen during peritoneal 
dialysis. However, it must be said that 
the model was one where infl ammation 
was produced not through recurrent 
dialyses but rather through the injection 
of an infl ammatory agent. Regardless, 
the results clearly have therapeutic 
potential. See page 227.
 
 
